Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI
Yıl: 2019 Cilt: 49 Sayı: 6 Sayfa Aralığı: 1626 - 1633 Metin Dili: İngilizce DOI: 10.3906/sag-1906-14 İndeks Tarihi: 15-05-2020
Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI
Öz: Background/aim: We aimed to evaluate the size/tortuosity of the optic nerve (ON) and the dilatation of the ON sheath (ONS) inneurofibromatosis type 1 (NF-1) patients with 3T-MRI, and to assess the usefulness of 3D-SPACE in imaging the optic pathway, ON,and ONS in NF-1 patients.Materials and methods: Twenty consecutive NF-1 patients without optic pathway glioma (OPG) (Group 1), 16 consecutive NF-1patients with OPG (Group 2), and 19 controls were included in this study. The thickness and tortuosity of the ON and the diameter ofthe ONS were measured on STIR and 3D-SPACE images.Results: The thickness of the ON was similar in all groups on STIR images (P>0.05). The mean ONS diameter was higher in Group 2with this sequence (P=0.009). Controls had significantly lower grades of ON tortuosity than Groups 1 and 2 (P=0.001), and Group 1 hadsignificantly lower ON tortuosity compared to Group 2 (P=0.001). Severe tortuosity was only detected in Group 2.Conclusion: ON tortuosity and ONS diameter were increased in NF-1 patients in the presence of OPG. High-resolution craniumimaging with the 3D-SPACE technique using 3T-MRI seems to be helpful for detection of the optic pathway morphology and pathologiesin NF-1 patients.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. Journal of Medical Genetics 2007; 44: 81-88.
- 2. Friedman JM. Neurofibromatosis 1. In: Pagon RA, Bird TC, Dolan CR, Stephens K (editors). Gene Reviews [Internet]. Seattle, WA, USA: University of Washington, Seattle; 1998.
- 3. Rosenfeld A, Listernick R, Charrow J, Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Child’s Nervous System 2010; 26: 663-667.
- 4. Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño J, García-Segura JM et al. Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients. Revista de Neurologia 2008; 46: 530-536.
- 5. Hernáiz Driever P, von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M et al. Natural history and management of low-grade glioma in NF-1 children. Journal of NeuroOncology 2010; 100: 199-207.
- 6. Zuccoli G, Ferrozzi F, Signorini M, Virdis G, Troiso G. Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach. La Radiologia Medica 2001; 101: 382-385.
- 7. Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A et al. Optic radiation involvement in optic pathway gliomas in neurofibromatosis. American Journal of Ophthalmology 2004; 137: 407-414.
- 8. Levin MH, Brodsky MC, Phillips PC, Belasco J, Janss A et al. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. British Journal of Ophthalmology 2016; 100: 510-514.
- 9. Dincer A, Yener U, Ozek MM. Hydrocephalus in patients with neurofibromatosis type 1: MR imaging findings and the outcome of endoscopic third ventriculostomy. American Journal of Neuroradiology 2011; 32: 643-646.
- 10. Maloney E, Stanescu AL, Perez FA, Iyer RS, Otto RK et al. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary? Pediatric Radiology 2018; 48: 1472-1484.
- 11. Algin O. Evaluation of hydrocephalus patients with 3D-SPACE technique using variant FA mode at 3T. Acta Neurologica Belgica 2018; 118: 169-178.
- 12. Armstrong GT, Localio AR, Feygin T, Bilaniuk L, Phillips PC et al. Defining optic nerve tortuosity. American Journal of Neuroradiology 2007; 28: 666-671.
- 13. Lövblad KO, Remonda L, Ozdoba C, Huber P, Schroth G. Dural ectasia of the optic nerve sheath in neurofibromatosis type 1: CT and MR features. Journal of Computer Assisted Tomography 1994; 18: 728-730.
- 14. Vanderveen DK, Nihalani BR, Barron P, Anderson RL. Optic nerve sheath fenestration for an isolated optic nerve glioma. Journal of AAPOS 2009; 13: 88-90.
- 15. Jungkim S, Khurshid SG, Fenton S. Dural ectasia of the optic nerve sheath. Acta Ophthalmologica Scandinavica 2005; 83: 266-267.
- 16. Bruce BB, Biousse V, Newman NJ. Update on idiopathic intracranial hypertension. American Journal of Ophthalmology 2011; 152: 163-169.
- 17. Ji J, Shimony J, Gao F, McKinstry RC, Gutmann DH. Optic nerve tortuosity in children with neurofibromatosis type 1. Pediatric Radiology 2013; 43: 1336-1343.
- 18. Mehrpour M, Oliaee Torshizi F, Esmaeeli S, Taghipour S, Abdollahi S. Optic nerve sonography in the diagnostic evaluation of pseudopapilledema and raised intracranial pressure: a cross-sectional study. Neurology Research International 2015; 2015: 146059.
- 19. Kang YS, Park EK, Kim YO, Kim JS, Kim DS et al. Altered cerebrospinal fluid dynamics in neurofibromatosis type l: severe arachnoid thickening in patients with neurofibromatosis type 1 may cause abnormal CSF dynamic. Child’s Nervous System 2017; 33: 767-775.
- 20. Algin O, Ucar M, Ozmen E, Borcek AO, Ozisik P et al. Assessment of third ventriculostomy patency with the 3D-SPACE technique: a preliminary multicenter research study. Journal of Neurosurgery 2015; 122: 1347-1355.
- 21. Algin O, Turkbey B, Ozmen E, Ocakoglu G, Karaoglanoglu M et al. Evaluation of aqueductal stenosis by 3D sampling perfection with application-optimized contrasts using different flip angle evolutions sequence: preliminary results with 3T MR imaging. American Journal of Neuroradiology 2012; 33: 740- 746.
- 22. Janthanimi P, Dumrongpisutikul N. Pediatric optic nerve and optic nerve sheath diameter on magnetic resonance imaging. Pediatric Radiology 2019; 49: 1071-1077.
| APA | Saraç Ö, ALGIN O, Beyazal M, Anlar B, Varan A, KANSU T (2019). Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. , 1626 - 1633. 10.3906/sag-1906-14 |
| Chicago | Saraç Özge,ALGIN Oktay,Beyazal Mehmet,Anlar Banu,Varan Ali,KANSU Tülay Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. (2019): 1626 - 1633. 10.3906/sag-1906-14 |
| MLA | Saraç Özge,ALGIN Oktay,Beyazal Mehmet,Anlar Banu,Varan Ali,KANSU Tülay Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. , 2019, ss.1626 - 1633. 10.3906/sag-1906-14 |
| AMA | Saraç Ö,ALGIN O,Beyazal M,Anlar B,Varan A,KANSU T Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. . 2019; 1626 - 1633. 10.3906/sag-1906-14 |
| Vancouver | Saraç Ö,ALGIN O,Beyazal M,Anlar B,Varan A,KANSU T Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. . 2019; 1626 - 1633. 10.3906/sag-1906-14 |
| IEEE | Saraç Ö,ALGIN O,Beyazal M,Anlar B,Varan A,KANSU T "Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI." , ss.1626 - 1633, 2019. 10.3906/sag-1906-14 |
| ISNAD | Saraç, Özge vd. "Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI". (2019), 1626-1633. https://doi.org/10.3906/sag-1906-14 |
| APA | Saraç Ö, ALGIN O, Beyazal M, Anlar B, Varan A, KANSU T (2019). Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Turkish Journal of Medical Sciences, 49(6), 1626 - 1633. 10.3906/sag-1906-14 |
| Chicago | Saraç Özge,ALGIN Oktay,Beyazal Mehmet,Anlar Banu,Varan Ali,KANSU Tülay Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Turkish Journal of Medical Sciences 49, no.6 (2019): 1626 - 1633. 10.3906/sag-1906-14 |
| MLA | Saraç Özge,ALGIN Oktay,Beyazal Mehmet,Anlar Banu,Varan Ali,KANSU Tülay Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Turkish Journal of Medical Sciences, vol.49, no.6, 2019, ss.1626 - 1633. 10.3906/sag-1906-14 |
| AMA | Saraç Ö,ALGIN O,Beyazal M,Anlar B,Varan A,KANSU T Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Turkish Journal of Medical Sciences. 2019; 49(6): 1626 - 1633. 10.3906/sag-1906-14 |
| Vancouver | Saraç Ö,ALGIN O,Beyazal M,Anlar B,Varan A,KANSU T Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Turkish Journal of Medical Sciences. 2019; 49(6): 1626 - 1633. 10.3906/sag-1906-14 |
| IEEE | Saraç Ö,ALGIN O,Beyazal M,Anlar B,Varan A,KANSU T "Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI." Turkish Journal of Medical Sciences, 49, ss.1626 - 1633, 2019. 10.3906/sag-1906-14 |
| ISNAD | Saraç, Özge vd. "Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI". Turkish Journal of Medical Sciences 49/6 (2019), 1626-1633. https://doi.org/10.3906/sag-1906-14 |
